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Abstract The hematopoietic cellular kinase (Hck) is a member 
of the Src family of non-receptor protein-tyrosine kinases and 
participates in signal transduction events regulating the growth, 
differentiation and function of phagocytes. The secondary 
structure of the SH2 domain for Hck was determined for a 
13C/15N-enriched sample using multi-dimensional NMR spec-
troscopy. The secondary structure for the domain was deter-
mined from chemical shift indices ['Ha, 1 3Ca and 1 3 C ] , 
sequential NOEs [</aN(i5 i+1) and (/NNO, i+1)], and
 3 /aN scalar 
coupling constants. The Hck SH2 domain consists of two 
a-helices and seven P-strands. Complementary strands of P-
sheets were identified from long-range NOEs using a novel 3D, 
13C/15N-edited HMQC-NOESY-(HCACO)NH experiment 
that correlated 'Ha resonances between P-strands. The second-
ary structure for Hck SH2 is similar to that predicted from the 
sequence alignment of the Src-family protein tyrosine kinases. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
The hematopoietic cellular kinase (Hck) is a Src-related 
protein tyrosine kinase that is expressed predominantly in 
granulocytes, monocytes and macrophages [1^4]. Two iso-
forms of human Hck (p59 and p61) are produced from a 
single transcript as a result of alternative sites for translational 
initiation [5]. Several lines of evidence support specific roles 
for Hck in functions associated with mature phagocytes. For 
example, the hck gene is strongly activated by agents that 
induce macrophage differentiation and priming of the respira-
tory burst [6,7]. Hck has been shown to associate with the Fc 
receptor and is stimulated in response to receptor activation 
[8-10]. Thus, Hck may serve as part of a signaling pathway 
coupling the Fc receptor to the activation of the respiratory 
burst. Hck has also been implicated in signal transduction by 
the urokinase plasminogen activator receptor, suggesting that 
Hck may contribute to neutrophil migration [11]. Finally, the 
p59 form of Hck localizes predominantly to the secretory 
granules of human neutrophils, suggesting that it may regu-
late the degranulation process as well [12]. 
Further evidence for Hck involvement in neutrophil and 
macrophage function comes from gene-knockout studies. 
Hematopoiesis was not detectably impaired in mice with ho-
mozygous deletions of Hck, although phagocytosis was af-
fected [13]. Interestingly, the tyrosine kinase activity of Lyn 
was increased in macrophages from the Hck knock-out ani-
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mals, suggestive of a possible mechanism to compensate for 
the loss of Hck. Evidence for functional overlap of Hck with 
other Src family members comes from analysis of double-mu-
tant animals. For example, mice with homozygous deletions 
of both Hck and Fgr demonstrated a loss of innate immunity 
to Listeria monocytogenes infection, a pathogen that is nor-
mally controlled by macrophages [13]. Similarly, the Hck/Fgr 
double-knockout animals demonstrated defects in integrin-
mediated responses in neutrophils, whereas animals with the 
individual knockouts showed essentially wild-type responses 
[14]. 
Other studies suggest that Hck may contribute to hemato-
poietic cytokine signal transduction. Hck activation has been 
reported in response to IL-3, GM-CSF, as well as the gpl30-
linked cytokine, LIF [15-17]. Overexpression of Hck in IL-3-
responsive cells led to a substantial increase in tyrosine phos-
phorylation following IL-3 treatment [17]. Src was not respon-
sive to IL-3 in similar experiments, indicative of specificity. In 
the case of LIF, constitutive activation of Hck by gene target-
ing in embryonic stem cells dramatically reduced the LIF 
requirement for maintenance of totipotency [16]. Hck was 
also found to physically associate with gpl30, the signal-trans-
ducing component of the LIF receptor that is shared with the 
receptors for IL-6 and other cytokines. These experiments 
suggest that Hck, together with other members of the Src 
kinase family, may regulate early embryogenesis. 
Hck, and other members of the Src kinase family, share 
similar structural organization and regulation [18]. The N-ter-
minal region bears sites for lipid attachment, including myr-
istylation and in some cases palmitylation. Both the p59 and 
p61 forms of Hck are myristylated, whereas only the smaller 
form is palmitylated. Differential lipid modification may ac-
count for the reported differences in subcellular localization of 
these two isoforms [19]. Adjacent to the N-terminal region are 
the SH3 and SH2 domains, followed by the kinase domain 
and negative regulatory tail. The SH2 domain, by virtue of its 
tyrosine phosphopeptide binding activity, as well as the tail 
region are essential for negative regulation of tyrosine kinase 
activity. Tyrosine phosphorylation of a conserved tyrosine 
residue in this region (Tyr°27 in Src; Tyr501 in Hck) is believed 
to promote intramolecular interaction of the tail with the SH2 
domain, restraining the kinase in an inactive conformation 
[18]. Dephosphorylation of the tail or displacement of the 
tail from the SH2 domain as a result of binding to another 
tyrosine-phosphorylated protein are two possible mechanisms 
for kinase activation [18]. In this regard, Hck has recently 
been shown to associate with the p210 form of Bcr/Abl, the 
oncogenic tyrosine kinase associated with chronic myeloge-
nous leukemia [20]. This association correlated with strong 
stimulation of Hck tyrosine kinase activity, implicating Hck 
in Bcr/Abl signal transduction. Activation of Hck may result 
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from disruption of SH2-tail interaction following binding to 
tyrosine-autophosphorylated Bcr/Abl. Thus, the SH2 domain 
of Hck plays a key role in the regulation of tyrosine kinase 
activity as well as interaction with other proteins. In this re-
port, we provide a complete secondary structural assignment 
for the Hck SH2 domain, the first structural data to be re-
ported for the Hck protein-tyrosine kinase in solution. 
HMQC-NOESY-(HCACO)NH experiment (Fig. 1). Three-bond cou-
pling constants (3/KN) were determined using JiNHA [32] and HMQC-
/ [33] experiments. Identification of amide NH in rapid exchange with 
H2O was done using the HSQC-exchange experiment [34]. All NMR 
data were processed with FELIX v2.05 (Hare Research, Inc., Bothel, 
WA) or NMRPipe [35] using a Sparc-20 workstation. 
3. Results and discussion 
2. Materials and methods 
2.1. Sample preparation 
The gene segment of hck encoding the SH2 domain (residues 119-
224) was amplified by PCR from a human hck cDNA [1] and inserted 
into the pET-14b (Novagen) plasmid vector. This vector was used to 
transform E. coli strain BL21(DE3)pLysS. The transformed cells were 
grown in M9 minimal medium [21] at 37°C. IPTG was added to the 
growth medium to induce protein expression after the cell density 
reached ~0.6. Cells were collected by centrifugation 4 h after induc-
tion, and lysed by sonication in a buffer containing 50 mM NaCl, 
2 mM EDTA, 1% benzamidine, and 20 mM HEPES at pH 7.5. Cell 
lysates were cleared at lOOOOOXg and the recombinant SH2 domain 
(107 residues including the N-terminal methionine from the plasmid 
vector) in the supernatant was purified using phosphocellulose cation 
exchange chromatography (PI 1, Whatman). Further purification was 
accomplished using gel-filtration chromatography (Sephacryl S-200, 
Sigma) in 100 mM NaCl, 50 mM sodium phosphate at pH 6.4. Sam-
ples of pure protein for NMR spectroscopy were concentrated using 
Centriprep-3 (Amicon). Isotopically enriched samples were prepared 
using the same procedure except that 15NH4C1 and [13C]glucose were 
used as the sole nitrogen and carbon sources, respectively. The mo-
lecular weight and amino acid composition of the purified SH2 do-
main was verified by mass spectrometry and amino acid composition 
analysis. All samples for NMR analysis were prepared in 90% H2O/ 
10% D20 containing 100 mM NaCl, 5 mM DTT-di0, and 50 mM 
sodium phosphate at pH 6.4 and sealed under argon. 
2.2. NMR experiments 
All NMR experiments were performed at 28°C using a Varian Unity 
500 NMR spectrometer equipped with a triple-resonance pulsed field 
(z)-gradient probe and amplifier. Sequential assignment of the Hck 
SH2 domain was accomplished using the CBCA(CO)NH [22] and 
CBCANH [23] experiments. Ambiguities in resonance assignment 
due to resonance overlap were resolved using HNCO [24], gd-HCACO 
[25] and a modified HCA(CO)N [26] experiments. NOEs involving 
amide protons were assigned using 3D 15N-edited NOESY-HSQC 
[27], 13C'-edited NOESY-H(N)CO [28], and 4D 15N/15N- and 13C/ 
16N-edited HMQC-NOESY-HSQC [29,30] experiments. NOEs be-
tween a-protons were detected using the 3D 15N-edited NOESY-
(HCACO)NH experiment [31] and a novel 3D 13C/15N-edited 
3.1. Sequential assignments 
Sequential resonance assignments were achieved using the 
3D CBCA(CO)NH [22] and CBCANH [23] experiments using 
the procedure described by Grzesiek and Bax [36]. Ambigu-
ities due to overlapped resonances were removed using 
HNCO [24], gd-HCACO [25] and the HCA(CO)N [26] experi-
ments. The HCA(CO)N pulse sequence was modified to in-
clude pulsed field gradient pulses for water suppression. The 
complete sequential assignment of the amide resonances for 
the Hck SH2 domain is shown in Fig. 2. 
3.2. Identification of secondary structure elements 
The secondary structure for the Hck SH2 domain was de-
termined from chemical shift indices [ :Ha, 13Ca and 1 3 C] , 
sequential NOEs [<s?aN(i, i+1) and d^^(\, i+1)],
 3 /ON scalar cou-
pling constants, and amide proton exchange information (Fig. 
3). The chemical shifts for the backbone : H a , 13Ca and 1 3 C 
resonances provides information useful for the identification 
of secondary structural elements of proteins [37]. The 13Ca 
and 1 3 C resonance frequencies are shifted downfield in re-
gions of a-helix compared to random coil values while the 
x Ha frequencies are shifted upheld in oe-helical regions. The 
xHa, 13Coc and 1 3 C backbone resonances also shift in regions 
of (3-sheet relative to random coil values; however, the polar-
ity of the chemical shift changes in this case are opposite to 
those observed in ce-helices. 
Sequential NOEs also provides valuable information con-
cerning the secondary structure of proteins [38]. Strong 
<4N0, i+1) NOEs are observed for regions of P-sheet while 
these same sequential NOEs are weak in regions of oc-helical 
secondary structure. Conversely, dmQ., i+1) NOEs are strong 
in oc-helices but weak in regions of P-sheet secondary struc-
ture. All possible sequential <foN(i, i+1) and ^NNO, i+1) NOEs 
were observed for the SH2 domain of Hck using a combina-
Fig. 1. Pulse sequence of the 3D 13C/15N-edited HMQC-NOESY-(HCACO)NH experiment. Narrow and wide bars represent 90° and 180° 
pulses, respectively. All pulses are applied along the x-axis unless otherwise indicated. 13C decoupling was achieved using the SEDUCE-1 mod-
ulation [45] at an RF field strength of 840 Hz. 15N decoupling was accomplished using a WALTZ-16 scheme [46]. The phase cycle is (bl =x, 
-x; (b2 = 2x, 2(-x); (b3=4x, 4(-x); (b4 = 8x, 8(-x); receiver = x, 2(-x), x, -x, 2x, 2(-x), 2x, -x, x, 2(-x), x. Quadrature detection in ti and Xi is 
achieved using the States-TPPI method [47] by incrementing the phases of (bl and (b4, independently. All other parameters are similar to those 
described for the 3D 16N-edited NOESY-(HCACO)NH experiment [31]. 
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Fig. 2. 15N HSQC spectrum of 15N-labeled Hck SH2, showing assignment of amide resonances. Backbone resonances are labeled with the resi-
due name followed by residue number in the sequence. Side chain NH of Trp and Arg are indicated with NH while side chain NH2 of Asn 
and Gin are indicated by NH2. 
tion of 3D 15N-edited NOESY-HSQC [27], 13C'-edited NO-
ESY-H(N)CO [28], and 4D 15N/15N- and 13C/15N-edited 
HMQC-NOESY-HSQC [29,30] experiments. The results are 
presented in Fig. 3. 
AHa 
ACa 
AC 
"NNO> 
3/ 
Fig. 3. Summary of sequentially dependent data of Hck SH2. AHa, ACa, and AC are the deviations of chemical shifts from random coil val-
ues for xHa, 13Ca, and 1 3 C , respectively. da^(i, i+1) and (/NNO, i+1) are sequential NOEs between residues i and i+1.
 37aN is the scalar cou-
pling constant between *Ha and backbone ^ N . fctra indicates amide protons which are in fast exchange with water in the HSQC-exchange ex-
periment [34]. 
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Fig. 4. Fl strips from the 3D 13C/15N-edited HMQC-NOESY-
(HCACO)NH spectrum of Hck SH2, showing four pairs of daa(i, j) 
NOEs in antiparallel P-sheet region. The data were obtained from a 
48(ti)X32(t2)X 512(i3) complex matrix with a spectrum width of 
6283, 1500, and 6000 Hz, respectively. A 16-step phase cycle and a 
relaxation delay of 0.8 s were used. The mixing period was 100 ms. 
The 3 / K N scalar coupling constant is a function of the back-
bone dihedral angle ((])) and is therefore dependent on protein 
secondary structure [38]. Residues involved in a-helical re-
gions are characterized by small values of 3 / 0 N ( < 6 Hz) while 
those embedded in (3-sheet have characteristically large values 
of 3 JaN ( > 8 Hz). The 3 / K N scalar coupling constants for the 
Hck SH2 domain were evaluated using HNHA [32] and 
HMQC-J [33] experiments. The results are presented in Fig. 
3. Excellent correlation is observed between residues with 
small values of 3JaN and those with sequential NOEs and 
chemical shift indices characteristic of a-helical secondary 
structure. Analogous results were also obtained for regions 
of (3-strand secondary structure. Amide proton exchange rates 
[34] also give information useful for the identification of sec-
ondary structural elements. In particular, residues having fast 
exchange rates for backbone XHN are normally located outside 
regions of well-defined a-helical or (3-strand secondary struc-
ture. A depiction of those backbone ^ N that are in rapid 
exchange with solvent is also included in Fig. 3. 
The location and nature of secondary structure elements for 
the Hck SH2 domain were identified by combining informa-
tion from chemical shift indices ^Ha , 13Ca and 1 3 C] , sequen-
tial NOEs [daN(i, i+1) and d^(\, i+1)],
 3 / K N scalar coupling 
constants, and amide proton exchange rates (Fig. 3). The Hck 
SH2 domain consists of two a-helices (residues 13-21 and 8 1 -
91) and seven fj-strands (residues 6-8, 29-34, 41^19, 55-65, 
69-72, 77-79, 81-91, and 101-103). The number and spacing 
of these secondary structural elements is similar to those re-
ported for other SH2 domains. 
Identification of partner (3-strands comprising a (3-sheet re-
quires assignment of long-range NOEs [daa(i, j), <4N(I, j) and 
dNN(i, j)]. Determination of NOEs between *Ha unambigu-
ously in water is a challenging task since some x Ha may 
resonate exactly at the 1 H 2 0 frequency. In order to overcome 
this difficulty, a novel 3D 13C/15N-edited HMQC-NOESY-
(HCACO)NH experiment was developed. The pulse sequence 
for this experiment is shown in Fig. 1. In this experiment, the 
*Ha from which the NOE originates is edited by the 13Ca 
chemical shift while the dipolar coupled : H a partner that is 
the destination of the NOE is correlated to the 15N chemical 
shift in the succeeding residue. Fig. 4 shows some of the Fl 
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strips of the 3D 1 3C/1 5N-edited H M Q C - N O E S Y - ( H C A -
C O ) N H spectrum for the Hck SH2 domain. Combined use 
of this new experiment with the 3D 15N-edited NOESY-
( H C A C O ) N H experiment [31], allowed unequivocal assign-
ment for all daa(i, j) N O E s in the anti-parallel P-sheets. A 
summary of the experimentally observed long-range N O E s 
in the anti-parallel P-sheet segments is presented in Fig. 5. 
Strong N O E s are indicated by thick arrows while medium 
N O E s are shown with thin arrows. 
Structures derived from heteronuclear multidimensional 
N M R data have been reported for the SH2 domains of c-
Abl [39], the C-terminal SH2 domain of PLC-yl [40], Crk 
[41], the N-terminal SH2 domain of PI 3 ' kinase [42], c-Src 
[43] and Blk [44]. In this report, we present the resonance 
assignments and secondary structure determination for the 
SH2 domain of the Src-family protein tyrosine kinase, Hck. 
Structural information concerning the Hck SH2 domain is 
essential both to enrich our understanding of the structural 
basis for SH2-ligand interactions, and also to understand the 
structural basis for signal transduction mediated by Hck, a 
protein that plays unique roles in the regulation of the 
growth, differentiation, and function of phagocytes (see Sec-
tion 1). 
4. Conclusions 
The sequential resonances for the Hck SH2 domain have 
been assigned and the secondary structure elements for this 
domain have been identified. The overall topology of the Hck 
SH2 domain is similar to that reported previously for the SH2 
domain of c-Src and consists of two cc-helices and seven P-
strands. The development of a novel 3D, 1 3C/1 5N-edited 
H M Q C - N O E S Y - H C A C O ( N H ) experiment permitted the un-
ambiguous assignments for all the strong rfaa(i, j) N O E s in the 
antiparallel p-sheets. The secondary structure information, 
along with a high resolution 3D structure, will be helpful in 
understanding the function of this domain critical for negative 
regulation and substrate recognition of Hck. Refinement of 
the 3D structure of Hck SH2 domain is in progress in our 
laboratory. 
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